On 10 April 2019 the EC published a Question and Answer (Q&A) document on the interplay between the Clinical Trials Regulation (CTR) and the General Data Protection Regulation (GDPR).
The document contains guidelines on the interaction between the two Regulations which will become relevant when the CTR becomes applicable, except for question 11 which refers to the current regime under the Clinical Trial Directive.
The note contains general obligations under the CTR as regards personal data and addresses the following issues:
This Q&A document reflects the state of play of the opinion adopted on 23 January 2019 by the European Data Protection Board (EDPB), an independent European body, which contributes to the consistent application of data protection rules in the European Union and promotes cooperation between supervisory boards. It provides useful guidelines on the interplay between the CTR and the GDPR in relation to the processing of personal data of people taking part to clinical trials. Also, it tries to clarify some reasonable doubts on the application of the appropriate provisions, considering the overlapping and interactions between the CTR and the GDPR.
The Clinical Trials Regulation is set to replace the Clinical Trials Directive. Although the Regulation entered into force on 16 June 2014, it will become applicable depending on the development of a fully functional EU clinical trials portal and database, which will be confirmed by an independent audit. The Regulation will come into application six months after the European Commission publishes a notice of this confirmation. The entry into application of the Regulation is currently estimated to occur in 2020.